What Is Immunometabolism?
July 23, 2026Core Framework & Diagram What Is Immune Engineering?
July 23, 2026
What Is Immune Engineering?
No longer waiting for the immune system to get stronger on its own — we're starting to directly redesign it
By the Editors 1-min read
Traditional immunotherapy activates or regulates the immune system — drugs remove blockades, letting immune cells work better.
Immune engineering goes further: it directly modifies immune cells themselves — rewriting their DNA, installing new receptors, deleting limiting genes, making them into 'super immune cells' impossible in their natural state.
This isn't science fiction — it's clinical reality already happening. CAR-T cells have achieved long-term remission in some blood tumors; CRISPR-edited T cells have entered human clinical trials; gene-engineered NK cells (CAR-NK) are rapidly advancing.
Understanding immune engineering is the entry point to understanding next-generation cancer treatment and immune disease treatment.
KEY TAKEAWAYS
01
Immune engineering's paradigm shift: from 'regulating the existing immune system' to 'directly modifying immune cells, giving them capabilities impossible in their natural state.'
02
CAR-T has complete remission rates over eighty percent in CD19+ blood tumors — immune engineering's most important clinical milestone so far. FDA approval of CD19-CAR-T in 2017 proved this path is viable.
03
CAR-NK is an important CAR-T evolution: lower GvHD and CRS risks, can use off-the-shelf allogeneic products, dual recognition mechanism (CAR + natural receptors), rapidly advancing in clinical use.
04
CRISPR advances immune engineering from 'installing new weapons' to 'fully rewriting cell gene programs' — knocking out PD-1, TET2, CISH and other genes comprehensively enhances immune cell persistence and combat effectiveness.
05
Solid tumors are immune engineering's next major battleground, challenges far greater than blood tumors (homing barriers, TME metabolic suppression, antigen diversity). Universal CAR-NK + metabolic enhancement + oncolytic virus combination is the most promising current strategy.
06
NK cell engineering (CAR-NK + CRISPR enhancement) represents one of immunotherapy's cutting-edge frontiers, sharing the same biological foundations and technical basis with NK cell therapy applications in anti-aging and cancer prevention.
Art 128
What Is Synthetic Immunology?
→
Art 129
What Is the Immune System Digital Twin?
→
